Scientific & Regulatory Review
-
Read FlipbookWCG Trifecta Partners with Major Japanese Pharmaceutical Sponsor to Unify the Management of Safety Records and Increase Compliance
WCG’s SafetyVigilance® Online Safety Event Solution Delivers Quality and Efficiency to Unify Enterprise Trial Management and Meet Regional Guidelines and Regulations
-
1:56Watch Video90 Second Insights: Safety Reporting in the Time of COVID-19
-
New Blog: "Ask the IRB Experts"
Visit Blog -
Read PostNew Normal or Not, Safety Reporting Matters
-
Read PostPeople, Process and Technology: The Right Combination for Successful Expert Committees
-
Read Flipbook
How A Top-Pharma Client Transformed Its Safety-Reporting Process, Saving $11.2 Million in One Year
-
53:35Watch VideoStump the Safety Experts Q&A
Our experts teamed-up to take on your safety questions and provide you with tactics and strategies to overcome the biggest challenges plaguing your studies today.
-
1:11Watch VideoAIMS 4.1 Promo
Custom-built to streamline the adjudication process, the AIMS platform allows for enhanced endpoint adjudication capabilities.
-
Read FlipbookAdvances in Oncology Extend Lives, but Lead to New Safety Considerations for Sponsors and Investigators
From cardiovascular adverse events to complex dosing regimens, oncology trials present unique safety-related considerations.
-
46:42Watch VideoSafety Reporting Reference Model: Optimizing Global Safety Reporting in Clinical Trials using Local Laws
-
PodcastPodcast: The Role of Expert Committees in Clinical Research with guest Jonathan Seltzer, MD, MBA, MA, FACC
-
Read FlipbookSomething Has to Give: The Current Unsustainable Approach to Safety Reporting Puts Trials and Patients at Risk
Something Has to Give: The Current Unsustainable Approach to Safety Reporting Puts Trials and Patients at Risk
-
Read FlipbookCase Study: Retrospective Endpoint Adjudication Committee
-
Read PostDe-risking Clinical Trials Through Analytic Supported, On-Demand Medical Expertise From The World’s Leading Clinical Trial Experts
-
Read FlipbookAssessing Cardiac Safety in Oncology Drug Development
This publication discusses emerging cardio-oncology nuances and the latest regulatory thinking on ways to manage risks.
-
32:32Watch VideoEliminating the Headache of Global Safety Reporting to Investigators and Ethics Committees
-
Read FlipbookOptimizing SUSAR distribution in a connected– but unharmonized–world
Steven Beales and Joe O’Rourke, vice president, business development talk through some of the difficulties Sponsors face when it comes to safety letter distribution, and how to overcome them.
-
13:58Watch VideoThe Role of Expert Committees: An interview with Dr. Seltzer
What’s the role of expert committees today? What’s happening on the regulatory side? Dr. Seltzer, Chief Scientific Officer of WCG Clinical, shared his insights on expert committees during a recent...
-
Read FlipbookDon’t Do It Alone: To De-Risk Your Next Trial, Seek Outside Expertise
Due to evolving practices and increased regulatory attention on expert committee operations, sponsors are turning more to independent providers with experience in managing expert committees.
-
34:46Watch VideoA Small Company’s Experience Managing Safety and Risk Mitigation Without Infrastructure Spend
-
Read FlipbookQ&A: The Role of Expert Committees and the Regulatory Landscape
Dr. Seltzer, president and founder of ACI Clinical, and chief scientific officer of WCG Clinical, shared his insights on expert committees during a recent conversation with Bill Stedman.
-
Loading More...
